Behavioral phenotypes and neurobiological mechanisms in the Shank1 mouse model for autism spectrum disorder: A translational perspective

Behavioural Brain Research

Volumn 352, Issue , 2018, Pages 46-61

  Sungur, A Özge ^a   Schwarting, Rainer K W ^a   Wöhr, Markus ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Hippocampus; Intellectual disability; Novel object recognition; Repetitive behavior; Shank2; Shank3; Social approach; Ultrasonic vocalizations

Indexed keywords

BRAIN PROTEIN; PROTEIN SHANK1; UNCLASSIFIED DRUG; NERVE PROTEIN; SHANK1 PROTEIN, HUMAN; SHANK1 PROTEIN, MOUSE;

AUTISM; BEHAVIOR DISORDER; GENE; GENE DELETION; HEREDITY; HETEROZYGOTE; HUMAN; KNOCKOUT MOUSE; MOLECULAR MECHANICS; MOUSE MODEL; MULTIGENE FAMILY; NEUROBIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SHANK1 GENE; SPECIES COMPARISON; SYMPTOMATOLOGY; TRANSLATIONAL RESEARCH; ANIMAL; DEFICIENCY; DISEASE MODEL; GENETICS; METABOLISM; PSYCHOLOGY;

ANIMALS; AUTISM SPECTRUM DISORDER; DISEASE MODELS, ANIMAL; HUMANS; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85030751483     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2017.09.038     Document Type: Review

References (166)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed., 2013, American Psychiatric Publishing, Arlington, VA, USA.
2. Baron-Cohen, S., Knickmeyer, R.C., Belmonte, M.K., Sex differences in the brain: implications for explaining autism. Science 310 (2005), 819–823.
3. Kanner, L., Autistic disturbances of affective contact. Nerv. Child 2 (1942), 217–253.
4. Asperger, H., Die “Autistischen Psychopathen im Kindesalter. Arch. Psychiatr. Nervenkr. 117 (1944), 76–136.
5. Frith, U., Autism: Explaining the Enigma. 2003, Blackwell Publishing, Oxford, UK.
6. Lai, M.C., Lombardo, M.V., Baron-Cohen, S., Autism. Lancet 383 (2014), 896–910.
7. Ronald, A., Hoekstra, R.A., Autism spectrum disorders and autistic traits: a decade of new twin studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156 B (2011), 255–274.
8. Bourgeron, T., From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat. Rev. Neurosci. 16 (2015), 551–563.
9. de la Torre-Ubieta, L., Won, H., Stein, J.L., Geschwind, D.H., Advancing the understanding of autism disease mechanisms through genetics. Nat. Med. 22 (2016), 345–361.
10. Guilmatre, A., Huguet, G., Delorme, R., Bourgeron, T., The emerging role of SHANK genes in neuropsychiatric disorders. Dev. Neurobiol. 74 (2014), 113–122.
11. Monteiro, P., Feng, G., SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat. Rev. Neurosci. 18 (2017), 147–157.
12. Durand, C.M., Betancur, C., Boeckers, T.M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I.C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.C., de Mas, P., Bieth, E., Rogé B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., Bourgeron, T., Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39 (2007), 25–27.
13. Betancur, C., Buxbaum, J.D., SHANK3 haploinsufficiency: a common but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders. Mol. Autism., 4, 2013, e17.
14. Bonaglia, M.C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., Zuffardi, O., Disruption of the ProSAP2 gene in a t(12;22)(q24 1;q13.3) is associated with the 22q13.3 deletion syndrome. Am. J. Hum. Genet. 69 (2011), 261–268.
15. Manning, M.A., Cassidy, S.B., Clericuzio, C., Cherry, A.M., Schwartz, S., Hudgins, L., Enns, G.M., Hoyme, E.H., Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics 114 (2004), 451–457.
16. Phelan, M.C., Rogers, R.C., Saul, R.A., Stapleton, G.A., Sweet, K., McDermid, H., Shaw, S.R., Claytor, J., Willis, J., Kelly, P.D., 22q13 deletion syndrome. Am. J. Med. Genet. 101 (2001), 91–99.
17. Wilson, H.L., Wong, A.C., Shaw, S.R., Tse, W.Y., Stapleton, G.A., Phelan, M.C., Hu, S., Marshall, J., McDermid, H.E., Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J. Med. Genet. 40 (2003), 575–584.
18. Sato, D., Lionel, A.C., Leblond, C.S., Prasad, A., Pinto, D., Walker, S., O'Connor, I., Russell, C., Drmic, I.E., Hamdan, F.F., Michaud, J.L., Endris, V., Roeth, R., Delorme, R., Huguet, G., Leboyer, M., Rastam, M., Gillberg, C., Lathrop, M., Stavropoulos, D.J., Anagnostou, E., Weksberg, R., Fombonne, E., Zwaigenbaum, L., Fernandez, B.A., Roberts, W., Rappold, G.A., Marshall, C.R., Bourgeron, T., Szatmari, P., Scherer, S.W., SHANK1 deletions in males with autism spectrum disorder. Am. J. Hum. Genet. 90 (2012), 879–887.
19. Wang, T., Guo, H., Xiong, B., Stessman, H.A., Wu, H., Coe, B.P., Turner, T.N., Liu, Y., Zhao, W., Hoekzema, K., Vives, L., Xia, L., Tang, M., Ou, J., Chen, B., Shen, Y., Xun, G., Long, M., Lin, J., Kronenberg, Z.N., Peng, Y., Bai, T., Li, H., Ke, X., Hu, Z., Zhao, J., Zou, X., Xia, K., Eichler, E.E., De novo genic mutations among a Chinese autism spectrum disorder cohort. Nat. Commun., 7, 2016, e13316.
20. Berkel, S., Marshall, C.R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., Bonin, M., Riess, A., Engels, H., Sprengel, R., Scherer, S.W., Rappold, G.A., Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42 (2010), 489–491.
21. Pinto, D., Pagnamenta, A.T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T.R., Correia, C., Abrahams, B.S., Almeida, J., Bacchelli, E., Bader, G.D., Bailey, A.J., Baird, G., Battaglia, A., Berney, T., Bolshakova, N., Bölte, S., Bolton, P.F., Bourgeron, T., Brennan, S., Brian, J., Bryson, S.E., Carson, A.R., Casallo, G., Casey, J., Chung, B.H., Cochrane, L., Corsello, C., Crawford, E.L., Crossett, A., Cytrynbaum, C., Dawson, G., de Jonge, M., Delorme, R., Drmic, I., Duketis, E., Duque, F., Estes, A., Farrar, P., Fernandez, B.A., Folstein, S.E., Fombonne, E., Freitag, C.M., Gilbert, J., Gillberg, C., Glessner, J.T., Goldberg, J., Green, A., Green, J., Guter, S.J., Hakonarson, H., Heron, E.A., Hill, M., Holt, R., Howe, J.L., Hughes, G., Hus, V., Igliozzi, R., Kim, C., Klauck, S.M., Kolevzon, A., Korvatska, O., Kustanovich, V., Lajonchere, C.M., Lamb, J.A., Laskawiec, M., Leboyer, M., Le Couteur, A., Leventhal, B.L., Lionel, A.C., Liu, X.Q., Lord, C., Lotspeich, L., Lund, S.C., Maestrini, E., Mahoney, W., Mantoulan, C., Marshall, C.R., McConachie, H., McDougle, C.J., McGrath, J., McMahon, W.M., Merikangas, A., Migita, O., Minshew, N.J., Mirza, G.K., Munson, J., Nelson, S.F., Noakes, C., Noor, A., Nygren, G., Oliveira, G., Papanikolaou, K., Parr, J.P., Parrini, B., Paton, T., Pickles, A., Pilorge, M., Piven, J., Ponting, C.P., Posey, D.J., Poustka, A., Poustka, F., Prasad, A., Ragoussis, J., Renshaw, K., Rickaby, J., Roberts, W., Roeder, K., Roge, B., Rutter, M.L., Bierut, L.J., Rice, J.P., Salt, J., Sansom, K., Sato, D., Segurado, R., Sequeira, A.F., Senman, L., Shah, N., Sheffield, V.C., Soorya, L., Sousa, I., Stein, O., Sykes, N., Stoppioni, V., Strawbridge, C., Tancredi, R., Tansey, K., Thiruvahindrapduram, B., Thompson, A.P., Thomson, S., Tryfon, A., Tsiantis, J., Van Engeland, H., Vincent, J.B., Volkmar, F., Wallace, S., Wang, K., Wang, Z., Wassink, T.H., Webber, C., Weksberg, R., Wing, K., Wittemeyer, K., Wood, S., Wu, J., Yaspan, B.L., Zurawiecki, D., Zwaigenbaum, L., Buxbaum, J.D., Cantor, R.M., Cook, E.H., Coon, H., Cuccaro, M.L., Devlin, B., Ennis, S., Gallagher, L., Geschwind, D.H., Gill, M., Haines, J.L., Hallmayer, J., Miller, J., Monaco, A.P., Nurnberger, J.I. Jr., Paterson, A.D., Pericak-Vance, M.A., Schellenberg, G.D., Szatmari, P., Vicente, A.M., Vieland, V.J., Wijsman, E.M., Scherer, S.W., Sutcliffe, J.S., Betancur, C., Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466 (2010), 368–372.
22. Gauthier, J., Spiegelman, D., Piton, A., Lafrenière, R.G., Laurent, S., St-Onge, J., Lapointe, L., Hamdan, F.F., Cossette, P., Mottron, L., Fombonne, E., Joober, R., Marineau, C., Drapeau, P., Rouleau, G.A., Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 150 (2009), 421–424.
23. Moessner, R., Marshall, C.R., Sutcliffe, J.S., Skaug, J., Pinto, D., Vincent, J., Zwaigenbaum, L., Fernandez, B., Roberts, W., Szatmari, P., Scherer, S.W., Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81 (2007), 1289–1297.
24. Leblond, C.S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Konyukh, M., Chaste, P., Ey, E., Rastam, M., Anckarsäter, H., Nygren, G., Gillberg, I.C., Melke, J., Toro, R., Regnault, B., Fauchereau, F., Mercati, O., Lemière, N., Skuse, D., Poot, M., Holt, R., Monaco, A.P., Järvelä I., Kantojärvi, K., Vanhala, R., Curran, S., Collier, D.A., Bolton, P., Chiocchetti, A., Klauck, S.M., Poustka, F., Freitag, C.M., Waltes, R., Kopp, M., Duketis, E., Bacchelli, E., Minopoli, F., Ruta, L., Battaglia, A., Mazzone, L., Maestrini, E., Sequeira, A.F., Oliveira, B., Vicente, A., Oliveira, G., Pinto, D., Scherer, S.W., Zelenika, D., Delepine, M., Lathrop, M., Bonneau, D., Guinchat, V., Devillard, F., Assouline, B., Mouren, M.C., Leboyer, M., Gillberg, C., Boeckers, T.M., Bourgeron Genetic, T., functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet., 8, 2012, e1002521.
25. Leblond, C.S., Nava, C., Polge, A., Gauthier, J., Huguet, G., Lumbroso, S., Giuliano, F., Stordeur, C., Depienne, C., Mouzat, K., Pinto, D., Howe, J., Lemière, N., Durand, C.M., Guibert, J., Ey, E., Toro, R., Peyre, H., Mathieu, A., Amsellem, F., Rastam, M., Gillberg, I.C., Rappold, G.A., Holt, R., Monaco, A.P., Maestrini, E., Galan, P., Heron, D., Jacquette, A., Afenjar, A., Rastetter, A., Brice, A., Devillard, F., Assouline, B., Laffargue, F., Lespinasse, J., Chiesa, J., Rivier, F., Bonneau, D., Regnault, B., Zelenika, D., Delepine, M., Lathrop, M., Sanlaville, D., Schluth-Bolard, C., Edery, P., Perrin, L., Tabet, A.C., Schmeisser, M.J., Boeckers, T.M., Coleman, M., Sato, D., Szatmari, P., Scherer, S.W., Rouleau, G.A., Betancur, C., Leboyer, M., Gillberg, C., Delorme, R., Bourgeron, T., Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. PLoS Genet., 10, 2014, e1004580.
26. Robinson, E.B., Lichtenstein, P., Anckarsäter, H., Happé F., Ronald, A., Examining and interpreting the female protective effect against autistic behavior. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 5258–5262.
27. Park, H., Kim, J.I., Ju, Y.S., Gokcumen, O., Mills, R.E., Kim, S., Lee, S., Suh, D., Hong, D., Kang, H.P., Yoo, Y.J., Shin, J.Y., Kim, H.J., Yavartanoo, M., Chang, Y.W., Ha, J.S., Chong, W., Hwang, G.R., Darvishi, K., Kim, H., Yang, S.J., Yang, K.S., Kim, H., Hurles, M.E., Scherer, S.W., Carter, N.P., Tyler-Smith, C., Lee, C., Seo, J.S., Discovery of common Asian copy number variants using intergrated high-resolution array CGH and massively parallel DNA sequencing. Nat. Genet. 42 (2010), 400–405.
28. Fromer, M., Pocklington, A.J., Kavanagh, D.H., Williams, H.J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D.M., Carrera, N., Humphreys, I., Johnson, J.S., Roussos, P., Barker, D.D., Banks, E., Milanova, V., Grant, S.G., Hannon, E., Rose, S.A., Chambert, K., Mahajan, M., Scolnick, E.M., Moran, J.L., Kirov, G., Palotie, A., McCarroll, S.A., Holmans, P., Sklar, P., Owen, M.J., Purcell, S.M., O'Donovan, M.C., De novo mutations in schizophrenia implicate synaptic networks. Nature 506 (2014), 179–184.
29. Jiang, Y.H., Ehlers, M.D., Modeling autism by SHANK gene mutations in mice. Neuron 78 (2013), 8–27.
30. Sheng, M., Kim, E., The Shank family of scaffold proteins. J. Cell Sci. 113 (2000), 1851–1856.
31. Ehlers, M.D., Synapse structure: glutamate receptors connected by the shanks. Curr. Biol. 9 (1999), 848–850.
32. Grabrucker, A.M., Schmeisser, M.J., Schoen, M., Boeckers, T.M., Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol. 21 (2011), 594–603.
33. Naisbitt, S., Kim, E., Tu, J.C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R.J., Worley, P.F., Sheng Shank, M., A novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23 (1999), 569–582.
34. Tu, J.C., Xiao, B., Naisbitt, S., Yuan, J.P., Petralia, R.S., Brakeman, P., Doan, A., Aakalu, V.K., Lanahan, A.A., Sheng, M., Worley, P.F., Coupling of metabotropic glutamate receptor/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23 (1999), 583–592.
35. Uchino, S., Wada, H., Honda, S., Nakamura, Y., Ondo, Y., Uchiyama, T., Tsutsumi, M., Suzuki, E., Hirasawa, T., Kohsaka, S., Direct interaction of post-synaptic density-95/Dlg/ZO-1 domain-containing synapticmolecule Shank3 with GluR1 alpha-amino-3-hydroxy-5-methyl-4 isoxazole propionic acid receptor. J. Neurochem. 97 (2006), 1203–1214.
36. Verpelli, C., Dvoretskova, E., Vicidomini, C., Rossi, F., Chiappalone, M., Schoen, M., Di Stefano, B., Mantegazza, R., Broccoli, V., Böckers, T.M., Dityatev, A., Sala, C., Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J. Biol. Chem. 286 (2011), 34839–34850.
37. Sala, C., Vicidomini, C., Bigi, I., Mossa, A., Verpelli, C., Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders. J. Neurochem. 135 (2015), 849–858.
38. Ting, J.T., Peça, J., Feng, G., Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annu. Rev. Neurosci. 35 (2012), 49–71.
39. Peça, J., Feliciano, C., Ting, J.T., Wang, W., Wells, M.F., Venkatraman, T.N., Lascola, C.D., Fu, Z., Feng, G., Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472 (2011), 437–442.
40. Hung, A.Y., Futai, K., Sala, C., Valtschanoff, J.G., Ryu, J., Woodworth, M.A., Kidd, F.L., Sung, C.C., Miyakawa, T., Bear, M.F., Weinberg, R.J., Sheng, M., Smaller dendritic spines weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J. Neurosci. 28 (2008), 1697–1708.
41. Schmeisser, M.J., Ey, E., Wegener, S., Bockmann, J., Stempel, A.V., Kuebler, A., Janssen, A.L., Udvardi, P.T., Shiban, E., Spilker, C., Balschun, D., Skryabin, B.V., Dieck, S.T., Smalla, K.H., Montag, D., Leblond, C.S., Faure, P., Torquet, N., Le Sourd, A.M., Toro, R., Grabrucker, A.M., Shoichet, S.A., Schmitz, D., Kreutz, M.R., Bourgeron, T., Gundelfinger, E.D., Boeckers, T.M., Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486 (2012), 256–260.
42. Won, H., Lee, H.R., Gee, H.Y., Mah, W., Kim, J.I., Lee, J., Ha, S., Chung, C., Jung, E.S., Cho, Y.S., Park, S.G., Lee, J.S., Lee, K., Kim, D., Bae, Y.C., Kaang, B.K., Lee, M.G., Kim, E., Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486 (2012), 261–265.
43. Bangash, M.A., Park, J.M., Melnikova, T., Wang, D., Jeon, S.K., Lee, D., Syeda, S., Kim, J., Kouser, M., Schwartz, J., Cui, Y., Zhao, X., Speed, H.E., Kee, S.E., Tu, J.C., Hu, J.H., Petralia, R.S., Linden, D.J., Powell, C.M., Savonenko, A., Xiao, B., Worley, P.F., Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 145 (2011), 758–772.
44. Bozdagi, O., Sakurai, T., Papapetrou, D., Wang, X., Dickstein, D.L., Takahashi, N., Kajiwara, Y., Yang, M., Katz, A.M., Scattoni, M.L., Harris, M.J., Saxena, R., Silverman, J.L., Crawley, J.N., Zhou, Q., Hof, P.R., Buxbaum, J.D., Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism., 1, 2010, 15.
45. Wang, X., McCoy, P.A., Rodriguiz, R.M., Pan, Y., Je, H.S., Roberts, A.C., Kim, C.J., Berrios, J., Colvin, J.S., Bousquet-Moore, D., Lorenzo, I., Wu, G., Weinberg, R.J., Ehlers, M.D., Philpot, B.D., Beaudet, A.L., Wetsel, W.C., Jiang, Y.H., Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 20 (2011), 3093–3108.
46. Silverman, J.L., Yang, M., Lord, C., Crawley, J.N., Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11 (2010), 490–502.
47. Wöhr, M., Scattoni, M.L., Behavioural methods used in rodent models of autism spectrum disorders: current standards and new developments. Behav. Brain. Res. 251 (2013), 5–17.
48. Santini, E., Klann, E., Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders. Sci. Signal., 7, 2014, re10.
49. Yoo, J., Bakes, J., Bradley, C., Collingridge, G.L., Kaang, B.K., Shank mutant mice as an animal model of autism. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 369, 2013, 20130143.
50. Silverman, J.L., Turner, S.M., Barkan, C.L., Tolu, S.S., Saxena, R., Hung, A.Y., Sheng, M., Crawley, J.N., Sociability and motor functions in Shank1 mutant mice. Brain Res. 1380 (2011), 120–137.
51. Sungur, A.Ö., Jochner, M.C.E., Harb, H., Kılıç A., Garn, H., Schwarting, R.K.W., Wöhr, M., Aberrant cognitive phenotypes and altered hippocampal BDNF expression related to epigenetic modifications in mice lacking the post-synaptic scaffolding protein SHANK1: Implications for autism spectrum disorder. Hippocampus 27 (2017), 906–919.
52. Sungur, A.Ö., Schwarting, R.K.W., Wöhr, M., Early communication deficits in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context. Autism Res. 9 (2016), 696–709.
53. Sungur, A.Ö., Vörckel, K.J., Schwarting, R.K.W., Wöhr, M., Repetitive behaviors in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context. J. Neurosci. Methods 234 (2014), 92–100.
54. Wöhr, M., Ultrasonic vocalizations in Shank mouse models for autism spectrum disorders: detailed spectrographic analyses and developmental profiles. Neurosci. Biobehav. Rev. 43 (2014), 199–212.
55. Wöhr, M., Roullet, F.I., Hung, A.Y., Sheng, M., Crawley, J.N., Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One, 6, 2011, e20631.
56. Zippelius, H.M., Schleidt, W.M., Ultraschall-Laute bei jungen Mäusen. Naturwissenschaften, 43, 1956, 502.
57. Sewell, G.D., Ultrasonic communication in rodents. Nature, 227, 1970, 410.
58. Ehret, G., Categorical perception of mouse-pup ultrasounds in the temporal domain. Anim. Behav. 43 (1992), 409–416.
59. Ehret, G., Haack, B., Categorial perception of mouse pup ultrasound by lactating females. Naturwissenschaften, 68, 1981, 208.
60. Ehret, G., Haack, B., Ultrasound recognition in house mice: key-stimulus configuration and recognition mechanisms. J. Comp. Physiol. 148 (1982), 245–251.
61. Bell, R.W., Nitschke, W., Zachman, T.A., Ultra-Sounds in three inbred strains of young mice. Behav. Biol. 7 (1972), 805–814.
62. Robinson, D.J., D'Udine, B., Ultrasonic calls produced by three laboratory strains of Mus Musculus. J. Zool. Lond. 197 (1982), 383–389.
63. Scattoni, M.L., Gandhy, S.U., Ricceri, L., Crawely, J.N., Unusual repertoire of vocalizations in the BTBR T + tf/J mouse model of autism. PLoS One, 3, 2008, e3067.
64. Branchi, I., Santucci, D., Vitale, A., Alleva, E., Ultrasonic vocalizations by infant laboratory mice: a preliminary spectrographic characterization under different conditions. Dev. Psychobiol. 33 (1998), 249–256.
65. D'Amato, F.R., Cabib, S., Chronic exposure to a novel odor increases pups’ vocalizations, maternal care, and alters dopaminergic functioning in developing mice. Behav. Neural Biol. 48 (1987), 197–205.
66. Moles, A., Kieffer, B.L., D'Amato, F.R., Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science 304 (2004), 1983–1986.
67. Wöhr, M., Effect of social odor context on the emission of isolation-induced ultrasonic vocalizations in the BTBR T + tf/J mouse model for autism. Front. Neurosci., 9, 2015, 73.
68. Panksepp, J.B., Jochman, K.A., Kim, J.U., Koy, J.J., Wilson, E.D., Chen, Q., Wilson, C.R., Lahvis, G.P., Affiliative behavior, ultrasonic communication and social reward are influenced by genetic variation in adolescent mice. PLoS One, 2, 2007, e351.
69. Hamilton, S.M., Spencer, C.M., Harrison, W.R., Yuva-Paylor, L.A., Graham, D.F., Daza, R.A., Hevner, R.F., Overbeek, P.A., Paylor, R., Multiple autism-like behaviors in a novel transgenic mouse model. Behav. Brain Res. 218 (2011), 29–41.
70. Scattoni, M.L., Martire, A., Cartocci, G., Ferrante, A., Ricceri, L., Reduced social interaction behavioural flexibility and BDNF signalling in the BTBR T+ tf/J strain, a mouse model of autism. Behav. Brain Res. 251 (2013), 35–40.
71. Ey, E., Torquet, N., Le Sourd, A.M., Leblond, C.S., Boeckers, T.M., Faure, P., Bourgeron, T., The autism PROSAP1/Shank2 mouse model displays quantitative and structural abnormalities in ultrasonic vocalizations. Behav. Brain Res. 256 (2013), 677–689.
72. Whitney, G., Coble, J.R., Stockton, M.D., Tilson, E.F., Ultrasonic emissions: do they facilitate courtship of mice?. J. Comp. Physiol. Psychol. 84 (1973), 445–452.
73. Ey, E., Yang, M., Katz, A.M., Woldeyohannes, L., Silverman, J.L., Leblond, C.S., Faure, P., Torquet, N., Le Sourd, A.M., Bourgeron, T., Crawley, J.N., Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4. Genes Brain Behav. 11 (2012), 928–941.
74. Chabout, J., Serreau, P., Ey, E., Bellier, L., Aubin, T., Bourgeron, T., Granon, S., Adult male mice emit context-specific ultrasonic vocalizations that are modulated by prior isolation or group rearing environment. PLoS One, 7, 2012, e29401.
75. Sales, G.D., Ultrasound and aggressive behaviour in rats and other small mammals. Anim. Behav. 20 (1972), 88–100.
76. Sewell, G.D., Ultrasound in adult rodents. Nature, 215, 1967, 512.
77. Dizinno, G., Whitney, G., Nyby, J., Ultrasonic vocalizations by male mice (Mus musculus) to female sex pheromone: experimental determinants. Behav. Biol. 22 (1978), 104–113.
78. Guo, Z., Holy, T.E., Sex selectivity of mouse ultrasonic songs. Chem. Senses 23 (2007), 463–473.
79. Maggio, J.C., Maggio, J.H., Whitney, G., Experience-based vocalization of male mice to female chemosignals. Physiol. Behav. 31 (1983), 269–272.
80. Nyby, J., Bigelow, J., Kerchner, M., Barbehenn, F., Male mouse (Mus musculus) ultrasonic vocalizations to female urine: why is heterosexual experience necessary?. Behav. Neural. Biol. 38 (1983), 32–46.
81. Roullet, F.I., Wöhr, M., Crawley, J.N., Female urine-induced male mice ultrasonic vocalizations but not scent-marking, is modulated by social experience. Behav. Brain. Res. 216 (2011), 19–28.
82. Hammerschmidt, K., Radyushkin, K., Ehrenreich, H., Fischer, J., Female mice respond to male ultrasonic ‘songs’ with approach behaviour. Biol. Lett. 5 (2009), 589–592.
83. Musolf, K., Hoffmann, F., Penn, D.J., Ultrasonic courtship vocalizations in wild house mice Mus musculus. Anim. Behav. 79 (2010), 757–764.
84. Pomerantz, S.M., Nunez, A.A., Bean, N.J., Female behavior is affected by male ultrasonic vocalizations in house mice. Physiol. Behav. 31 (1983), 91–96.
85. Arakawa, H., Blanchard, D.C., Arakawa, K., Dunlap, C., Blanchard, R.J., Scent marking behavior as an odorant communication in mice. Neurosci. Biobehav. Rev. 32 (2008), 1236–1248.
86. Wöhr, M., Moles, A., Schwarting, R.K.W., D'Amato, F.R., Lack of social exploratory activation in male μ-opioid receptor KO mice in response to playback of female ultrasonic vocalizations. Soc. Neurosci. 6 (2011), 76–87.
87. Fitch, W.T., Huber, L., Bugnyar, T., Social cognition and the evolution of language: constructing cognitive phylogenies. Neuron 65:201 (2016), 795–814.
88. Scharff, C., Petri, J., Evo-devo: deep homology and FoxP2: implications for the evolution of speech and language. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 366 (2011), 2124–2140.
89. Lennertz, L., Wagner, M., Wölwer, W., Schuhmacher, A., Frommann, I., Berning, J., Schulze-Rauschenbach, S., Landsberg, M.W., Steinbrecher, A., Alexander, M., Franke, P.E., Pukrop, R., Ruhrmann, S., Bechdolf, A., Gaebel, W., Klosterkötter, J., Häfner, H., Maier, W., Mössner, R., A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur. Arch. Psychiatry Clin. Neurosci. 262 (2012), 117–124.
90. Kouser, M., Speed, H.E., Dewey, C.M., Reimers, J.M., Widman, A.J., Gupta, N., Liu, S., Jaramillo, T.C., Bangash, M., Xiao, B., Worley, P.F., Powell, C.M., Loss of predominant Shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission. J. Neurosci. 33 (2013), 18448–18468.
91. Kalueff, A.V., Stewart, A.M., Song, C., Berridge, K.C., Graybiel, A.M., Fentress, C.J., Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat. Rev. Neurosci. 17 (2016), 45–59.
92. Baron-Cohen, S., Do autistic children have obsessions and compulsions?. Br. J. Clin. Psychol. 28 (1989), 193–200.
93. Carruthers, P., Autism as mind-blindness: an elaboration and partial defence. Carruthers, P., Smith, P.K., (eds.) Theories of Theories of Mind, 1996, Cambridge University Press, Cambridge UK, 257–273.
94. Asendorpf, J., Nichtreaktive Stressmessung: Bewegungsstereotypien als Aktivierungs-indikatoren. Z. Exp. Angew. Psychol. 27 (1980), 44–58.
95. Turner, M., Annotation Repetitive behavior in autism: a review of psychological research. J. Child. Psychol. Psychiatry 40 (1999), 839–849.
96. Berkel, S., Tang, W., Treviño, M., Vogt, M., Obenhaus, H.A., Gass, P., Scherer, S.W., Sprengel, R., Schratt, G., Rappold, G.A., Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology. Hum. Mol. Genet. 21 (2012), 344–357.
97. Jaramillo, T.C., Speed, H.E., Xuan, Z., Reimers, J.M., Liu, S., Powell, C.M., Altered striatal synaptic function and abnormal behaviour in Shank3 exon4-9 deletion mouse model of autism. Autism Res. 9 (2016), 350–375.
98. Yang, M., Bozdagi, O., Scattoni, M.L., Wöhr, M., Roullet, F.I., Katz, A.M., Abrams, D.N., Kalikhman, D., Simon, H., Woldeyohannes, L., Zhang, J.Y., Harris, M.J., Saxena, R., Silverman, J.L., Buxbaum, J.D., Crawley, J.N., Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J. Neurosci. 32 (2012), 6525–6541.
99. Filice, F., Vörckel, K.J., Sungur, A.Ö., Wöhr, M., Schwaller, B., Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism. Mol. Brain., 9, 2016, e10.
100. Mao, W., Watanabe, T., Cho, S., Frost, J.L., Truong, T., Zhao, X., Futai, K., Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons. Eur. J. Neurosci. 41 (2015), 1025–1035.
101. Eichenbaum, H., The role of the hippocampus in navigation is memory. J. Neurophysiol. 117 (2017), 1785–1796.
102. Morris, R.G., Garrud, P., Rawlins, J.N., O'Keefe, J., Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982), 681–683.
103. Maren, S., Phan, K.L., Liberzon, I., The contextual brain: implications for fear conditioning: extinction and psychopathology. Nat. Rev. Neurosci. 14 (2013), 417–428.
104. Kim, J.J., Fanselow, M.S., Modality-specific retrograde amnesia of fear. Science 256 (1992), 675–677.
105. Antunes, M., Biala, G., The novel object recognition memory: neurobiology test procedure, and its modifications. Cogn. Process. 13 (2012), 93–110.
106. Dere, E., Huston, J.P., de Souza Silva, M.A., The pharmacology: neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci. Biobehav. Rev. 31 (2007), 673–704.
107. Hitti, F.L., Siegelbaum, S.A., The hippocampal CA2 region is essential for social memory. Nature 508 (2014), 88–92.
108. Piskorowski, R.A., Nasrallah, K., Diamantopoulou, A., Mukai, J., Hassan, S.I., Siegelbaum, S.A., Gogos, J.A., Chevaleyre, V., Age-dependent specific changes in area CA2 of the hippocampus and social memory deficit in a mouse model of the 22q11 2 deletion syndrome. Neuron 89 (2016), 163–176.
109. Boeckers, T.M., Segger-Junius, M., Iglauer, P., Bockmann, J., Gundelfinger, E.D., Kreutz, M.R., Richter, D., Kindler, S., Kreienkamp, H.J., Differential expression and dendritic transcript localization of Shank family members: identification of a dendritic targeting element in the 3’ untranslated region of Shank1 mRNA. Mol. Cell Neurosci. 26 (2004), 182–190.
110. Zitzer, H., Honck, H.H., Bachner, D., Richter, D., Kreienkamp, H.J., Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain. J. Biol. Chem. 274 (1999), 32997–33001.
111. Epstein, I., Tushev, G., Will, T.J., Vlatkovic, I., Cajigas, I.J., Schuman, E.M., Alternative polyadenylation and differential expression of Shank mRNAs in the synaptic neuropil. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 369, 2014, e20130137.
112. Kasai, H., Fukuda, M., Watanabe, S., Hayashi-Takagi, A., Noguchi, J., Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci. 33 (2010), 121–129.
113. Barde, Y.A., Edgar, D., Thoenen, H., Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1 (1982), 549–553.
114. Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masiakowski, P., Thoenen, H., Barde, Y.A., Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341 (1989), 149–152.
115. Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., Bonhoeffer, T., Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 8856–8860.
116. Cowansage, K.K., LeDoux, J.E., Monfils, M.H., Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr. Mol. Pharmacol. 3 (2010), 12–29.
117. Park, H., Poo, M.M., Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 14 (2013), 7–23.
118. Ebert, D.H., Greenberg, M.E., Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493 (2013), 327–337.
119. Nickl-Jockschat, T., Michel, T.M., The role of neurotrophic factors in autism. Mol. Psychiatry 16 (2011), 478–490.
120. Abdallah, M.W., Mortensen, E.L., Greaves-Lord, K., Larsen, N., Bonefeld-Jørgensen, E.C., Nørgaard-Pedersen, B., Hougaard, D.M., Grove, J., Neonatal levels of neurotrophic factors and risk of autism spectrum disorders. Acta Psychiatr. Scand. 128 (2013), 61–69.
121. Connolly, A.M., Chez, M., Streif, E.M., Keeling, R.M., Golumbek, P.T., Kwon, J.M., Riviello, J.J., Robinson, R.G., Neuman, R.J., Deuel, R.M., Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 59 (2006), 354–363.
122. Correia, C.T., Coutinho, A.M., Sequeira, A.F., Sousa, I.G., Lourenço Venda, L., Almeida, J.P., Abreu, R.L., Lobo, C., Miguel, T.S., Conroy, J., Cochrane, L., Gallagher, L., Gill, M., Ennis, S., Oliveira, G.G., Vicente, A.M., Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism. Genes Brain Behav. 9 (2010), 841–848.
123. Miyazaki, K., Narita, N., Sakuta, R., Miyahara, T., Naruse, H., Okado, N., Narita, M., Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev. 26 (2004), 292–295.
124. Nelson, K.B., Grether, J.K., Croen, L.A., Dambrosia, J.M., Dickens, B.F., Jelliffe, L.L., Hansen, R.L., Phillips, T.M., Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49 (2001), 597–606.
125. Muñoz, P.C., Aspé M.A., Contreras, L.S., Palacios, A.G., Correlations of recognition memory performance with expression and methylation of brain-derived neurotrophic factor in rats. Biol. Res. 43 (2010), 251–258.
126. Callaghan, C.K., Kelly, A.M., Neurotrophins play differential roles in short and long-term recognition memory. Neurobiol. Learn. Mem. 104 (2013), 39–48.
127. Ellegood, J., Anagnostou, E., Babineau, B.A., Crawley, J.N., Lin, L., Genestine, M., DiCicco-Bloom, E., Lai, J.K., Foster, J.A., Peñagarikano, O., Geschwind, D.H., Pacey, L.K., Hampson, D.R., Laliberté C.L., Mills, A.A., Tam, E., Osborne, L.R., Kouser, M., Espinosa-Becerra, F., Xuan, Z., Powell, C.M., Raznahan, A., Robins, D.M., Nakai, N., Nakatani, J., Takumi, T., van Eede, M.C., Kerr, T.M., Muller, C., Blakely, R.D., Veenstra-VanderWeele, J., Henkelman, R.M., Lerch, J.P., Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the hetereogeneity. Mol. Psychiatry 20 (2015), 118–125.
128. Amaral, D.G., Schumann, C.M., Nordahl, C.W., Neuroanatomy of autism. Trends Neurosci. 31 (2008), 137–145.
129. Almeida, L.E.F., Roby, C.D., Krueger Increased, B.K., BDNF expression in fetal brain in the valproic acid model of autism. Mol. Cell Neurosci. 59 (2014), 57–62.
130. Göttlicher, M., Minucci, S., Zhu, P., Krämer, O.H., Schimpf, A., Giavara, S., Sleeman, J.P., Lo Coco, F., Nervi, C., Pelicci, P.G., Heinzel, T., Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20 (2001), 6969–6978.
131. Louhivuori, V., Vicario, A., Uutela, M., Rantamäki, T., Louhivuori, L.M., Castrén, E., Tongiorgi, E., Akerman, K.E., Castrén, M.L., BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse. Neurobiol. Dis. 41 (2011), 469–480.
132. Uutela, M., Lindholm, J., Louhivuori, V., Wei, H., Louhivuori, L.M., Pertovaara, A., Akerman, K., Castrén, E., Castrén, M.L., Reduction of BDNF expression in Fmr1 knockout mice worsens cognitive deficits but improves hyperactivity and sensorimotor deficits. Genes Brain Behav. 11 (2012), 513–523.
133. Timmusk, T., Palm, K., Metsis, M., Reintam, T., Paalme, V., Saarma, M., Persson, H., Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10 (1993), 475–489.
134. Boulle, F., van den Hove, D.L., Jakob, S.B., Rutten, B.P., Hamon, M., van Os, J., Lesch, K.P., Lanfumey, L., Steinbusch, H.W., Kenis, G., Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol. Psychiatry 17 (2012), 584–596.
135. Tessarz, P., Kouzarides, T., Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell. Biol. 15 (2014), 703–708.
136. Bredy, T.W., Wu, H., Crego, C., Zellhoefer, J., Sun, Y.E., Barad, M., Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn. Mem. 14 (2007), 268–276.
137. Balschun, D., Wetzel, W., del Rey, A., Pitossi, F., Schneider, H., Zuschratter, W., Besedovsky, H.O., Interleukin-6: a cytokine to forget. FASEB J. 18 (2004), 1788–1790.
138. del Rey, A., Balschun, D., Wetzel, W., Randolf, A., Besedovsky, H.O., A cytokine network involving brain-borne IL-1β IL-1ra, IL-18, IL-6, and TNFα operates during long-term potentiation and learning. Brain Behav. Immun. 33 (2013), 15–23.
139. Petitto, J.M., McNamara, R.K., Gendreau, P.L., Huang, Z., Jackson, A.J., Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion. J. Neurosci. Res. 56 (1999), 441–446.
140. Masi, A., Quintana, D.S., Glozier, N., Lloyd, A.R., Hickie, I.B., Guastella, A.J., Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol. Psychiatry 20 (2015), 440–446.
141. Uchino, S., Waga, C., SHANK3 as an autism spectrum disorder-associated gene. Brain Dev. 35 (2013), 106–110.
142. Szyf, M., Prospects for the development of epigenetic drugs for CNS conditions. Nat. Rev. Drug Discov. 14 (2015), 461–474.
143. Somogyi, P., Klausberger, T., Defined types of cortical interneurone structure space and spike timing in the hippocampus. J. Physiol. 562 (2005), 9–26.
144. Toledo-Rodriguez, M., Goodman, P., Illic, M., Wu, C., Markram, H., Neuropeptide and calcium-binding protein gene expression profiles predict neuronal anatomical type in the juvenile rat. J. Physiol. 567 (2005), 401–413.
145. Marin, O., Interneuron dysfunction in psychiatric disorders. Nat. Rev. Neurosci. 13 (2012), 107–120.
146. Stoner, R., Chow, M.L., Boyle, M.P., Sunkin, S.M., Mouton, P.R., Roy, S., Wynshaw-Boris, A., Colamarino, S.A., Lein, E.S., Courchesne, E., Patches of disorganization in the neocortex of children with autism. N. Engl. J. Med. 370 (2014), 1209–1219.
147. Zikopoulos, B., Barbas, H., Changes in prefrontal axons may disrupt the network in autism. J. Neurosci. 30 (2010), 14595–14609.
148. Rubenstein, J.L., Merzenich, M.M., Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2 (2003), 255–267.
149. Gogolla, N., Leblanc, J.J., Quast, K.B., Südhof, T.C., Fagiolini, M., Hensch, T.K., Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J. Neurodev. Dis. 1 (2009), 172–181.
150. Fukuda, T., Itoh, M., Ichikawa, T., Washiyama, K., Goto, Y., Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J. Neuropathol. Exp. Neurol. 64 (2005), 537–544.
151. Giovanoli, S., Weber, L., Meyer, U., Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation. Brain Behav. Immun. 40 (2014), 48–54.
152. Gogolla, N., Takesian, A.E., Feng, G., Fagiolini, M., Hensch, T.K., Sensory integration in mouse insular cortex reflects GABA circuit maturation. Neuron 83 (2014), 894–905.
153. Meyer, U., Nyffeler, M., Yee, B.K., Knuesel, I., Feldon, J., Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav. Immun. 22 (2008), 469–486.
154. Peñagarikano, O., Abrahams, B.S., Herman, E.I., Winden, K.D., Gdalyahu, A., Dong, H., Sonnenblick, L.I., Gruver, R., Almajano, J., Bragin, A., Golshani, P., Trachtenberg, J.T., Peles, E., Geschwind, D.H., Absence of CNTNAP2 leads to epilepsy neuronal migration abnormalities, and core autism-related deficits. Cell 147 (2011), 235–246.
155. Selby, L., Zhang, C., Sun, Q.Q., Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci. Lett. 412 (2007), 227–232.
156. Stephenson, D.T., O'Neill, S.M., Narayan, S., Tiwari, A., Arnold, E., Samaroo, H.D., Du, F., Ring, R.H., Campbell, B., Pletcher, M., Vaidya, V.A., Morton, D., Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Mol. Autism., 2, 2011, 7.
157. Tripathi, P.P., Sgado, P., Scali, M., Viaggi, C., Casarosa, S., Simon, H.H., Vaglini, F., Crosini, G.U., Bozzi, Y., Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice. Neuroscience 159 (2009), 842–849.
158. Orduz, D., Bischop, D.P., Schwaller, B., Schiffmann, S.N., Gall, D., Parvalbumin tunes spike-timing and efferent short-term plasticity in striatal fast spiking interneurons. J. Physiol. 591 (2013), 3215–3232.
159. Berridge, M.J., Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia. Cell Tissue Res. 357 (2014), 477–492.
160. Schwaller, B., The regulation of a cell's Ca(2+) signaling toolkit: the Ca (2+) homeostasome. Adv. Exp. Med. Biol. 740 (2012), 1–25.
161. Wöhr, M., Orduz, D., Gregory, P., Moreno, H., Khan, U., Vörckel, K.J., Wolfer, D.P., Welzl, H., Gall, D., Schiffmann, S.N., Schwaller, B., Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities. Transl. Psychiatry, 5, 2015, e525.
162. Delorme, R., Ey, E., Toro, R., Leboyer, M., Gillberg, C., Bourgeron, T., Progress toward treatments for synaptic defects in autism. Nat. Med. 19 (2013), 685–694.
163. Silverman, J.L., Crawley, J.N., The promising trajectory of autism therapeutics discovery. Drug Discov. Today 19 (2014), 838–844.
164. Harony-Nicolas, H., Kay, M., Hoffmann, J.D., Klein, M.E., Bozdagi-Gunal, O., Riad, M., Daskalakis, N.P., Sonar, S., Castillo, P.E., Hof, P.R., Shapiro, M.L., Baxter, M.G., Wagner, S., Buxbaum, J.D., Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat. Elife, 6, 2017, e18904.
165. Ellenbroek, B., Youn, J., Rodent models in neuroscience research: is it a rat race?. Dis. Model. Mech. 9 (2016), 1079–1087.
166. Homberg, J.R., Wöhr, M., Alenina, N., Comeback of the rat in biomedical research. ACS Chem. Neurosci. 8 (2017), 900–903.